Picture of Amicus Therapeutics logo

FOLD — Amicus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

BioMarin to acquire Amicus Therapeutics for $4.8 Billion

Dec 19 (Reuters) - BioMarin Pharmaceutical BMRN.O said on Friday it will acquire Amicus Therapeutics FOLD.O in an all-cash deal worth about $4.8 billion.

 (Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo)

 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Amicus Therapeutics

See all news